U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
DNA (recombinant modified Vaccinia virus Ankara-derived vaccine vector MVA-HBV endogenous F11 promoter plus hepatitis B virus C-terminal fragment of pre-S1 protein fused with pre-S2 protein fused with non-functional polymerase fused with pre-C protein fu
Preferred Name English
Bavebegene Tovacivec
Common Name English
bavebegene tovacivec [INN]
Common Name English
recombinant non-replicating vaccinia virus (Modified Vaccinia Ankara strain [MVA]) encoding two codon-optimised fusion proteins adjacent to one another containing hepatitis B virus (HBV) antigens, with the first one comprising the C-terminal region of th
Common Name English
Code System Code Type Description
CAS
2857059-65-3
Created by admin on Wed Apr 02 20:09:00 GMT 2025 , Edited by admin on Wed Apr 02 20:09:00 GMT 2025
PRIMARY
NCI_THESAURUS
C211731
Created by admin on Wed Apr 02 20:09:00 GMT 2025 , Edited by admin on Wed Apr 02 20:09:00 GMT 2025
PRIMARY
INN
12932
Created by admin on Wed Apr 02 20:09:00 GMT 2025 , Edited by admin on Wed Apr 02 20:09:00 GMT 2025
PRIMARY
FDA UNII
47R2ZYV242
Created by admin on Wed Apr 02 20:09:00 GMT 2025 , Edited by admin on Wed Apr 02 20:09:00 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966